Basal ganglia calcification in Down's syndrome

Area of Science:

• Neuropathology
• Neurodegenerative Diseases

Background:

• Down syndrome (DS) is associated with neurological abnormalities.
• Basal ganglia calcification (BGC) is a known finding in some neurological conditions.
• The specific prevalence and characteristics of BGC in DS require further elucidation.

Purpose of the Study:

• To investigate the pathological features of basal ganglia calcification in patients with Down syndrome.
• To determine the age-related prevalence and localization of BGC in Down syndrome.
• To explore the potential relationship between BGC and vascular changes in the basal ganglia.

Main Methods:

• Pathological examination of basal ganglia tissue from 33 patients with Down syndrome (age > 1 year).
• Histological analysis to identify and characterize calcification.
• Assessment of adjacent blood vessels for calcification and amyloid degeneration.

Main Results:

• Forty-five percent of Down syndrome patients exhibited basal ganglia calcification.
• Calcification was consistently localized to the globus pallidus.
• BGC prevalence and severity increased with age, correlating with vascular amyloid degeneration.

Conclusions:

• Basal ganglia calcification is a frequent pathological finding in Down syndrome.
• The observed calcification in the globus pallidus is age-dependent.
• The co-occurrence of vascular amyloid degeneration suggests a potential pathogenetic link to BGC in Down syndrome.